Delitschia confertaspora was described from an isolate
from dung of a rock hyrax (Procavia capensis) collected in
Namibia (1). It was recognized as a new species based on the fact
that post-meiotic cell divisions in the asci resulted in 64-spored
asci, and the ascospores differed from the other two known
64-spored Delitschia species in their spore dimensions and
configuration of the germ slit and gelatinous sheath. A culture
extracts was active in an assay for influenza transcription
inhibitors. The active component was found to be a
2,6-diketopiperazine derivative, named flutimide, which inhibited a
cap-dependent endonuclease of influenza viral RNA polymerase, an
enzyme essential for transcription of influenza virus and its
replication in cell culture (2). The biosynthetic pathway leading
to flutimide in culture remains unknown. It likely arises from
modification of a cyclic dipeptide linked in a distinctive way, and
resulting from a 2-module non-ribosomal peptide synthase. Because
flutimide is constructed in an unusual way relative to other
epidithiodioxopiperazines and dipeptide-derived metabolites, the
genetic machinery encoding the enzymatic reactions for its
biosynthesis may be novel.
Delitischia species appear late in the coprophilous
fungal succession, and therefore are likely to contribute to the
deconstruction of more complex plant polymers. The late
successional success of Delitschia species also implies
that they likely defend their microhabitat from niche-overlapping
organisms through chemical interference (3, 4). Late successional
coprophilous fungi have demonstrated an exceptional potential for
antibiotic discovery, as evidenced by a high frequency of novel
antibiotics, especially antifungals, from limited efforts to screen
coprophilous strains (5).
1. F Peláez, JD Polishook, M
Valldosera, J Guarro. Mycotaxon 50, 115 (1994).
2. JE Tomassini et al. Antimicrob. Agents
Chemother. 40, 1189 (1996).
3. DT Wicklow, in The Fungal Community. Its
Organization and Role in the Ecosystem. 2nd Ed., G. C. Carroll, D.
T. Wicklow, Eds. (Marcel Dekker, Inc., New York, 1992), pp.
715-728.
4. JB Gloer, in Environmental and Microbial
Relationships, 2nd Ed. The Mycota IV, C. P. Kubicek, I. S.
Druzhinina, Eds. (Springer-Verlag, Berlin Heidelberg, 2007),
pp. 257-283.
5. GF Bills, JB Gloer, Z An. Curr. Opin.
Microbiol. 16, 549 (2013).
Genome Reference(s)
Haridas S, Albert R, Binder M, Bloem J, LaButti K, Salamov A, Andreopoulos B, Baker SE, Barry K, Bills G, Bluhm BH, Cannon C, Castanera R, Culley DE, Daum C, Ezra D, González JB, Henrissat B, Kuo A, Liang C, Lipzen A, Lutzoni F, Magnuson J, Mondo SJ, Nolan M, Ohm RA, Pangilinan J, Park HJ, RamÃrez L, Alfaro M, Sun H, Tritt A, Yoshinaga Y, Zwiers LH, Turgeon BG, Goodwin SB, Spatafora JW, Crous PW, Grigoriev IV
101 Dothideomycetes genomes: A test case for predicting lifestyles and emergence of pathogens.
Stud Mycol. 2020 Jun;96():141-153. doi: 10.1016/j.simyco.2020.01.003